Prognostic value of genomic damage in non-small-cell lung cancer.

doi:10.1038/bjc.1998.327

Article

Prognostic value of genomic damage in non-small-cell lung cancer.

British journal of cancer - 1 Jun 1998

de Juan C, Iniesta P, Vega F J, Peinado M A, Fernandez C, Caldés T, Massa M J, López J A, Sánchez A, Torres A J, Balibrea J L, Benito M

Abstract excerpt

Genomic alterations have been analysed in 65 non-small-cell lung cancer (NSCLC) tissue samples by using the arbitrarily primed polymerase chain reaction (AP-PCR), which is a PCR-based genomic fingerprinting. We have shown that AP-PCR may be applied as a useful and feasible practical method for de...

Topics

Adult
Aged
Carcinoma, Non-Small-Cell Lung
DNA Fingerprinting
Female
Genes, myc
Genes, p53
Genes, ras
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Polymerase Chain Reaction

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.